GL1X · GenesisL1 explorer

MolNFT v1 · #118320 · protein

Crystal structure of C-met in complex with naphthyridinone inhibitor 5

5EYC · Hepatocyte growth factor receptor: “Crystal structure of C-met in complex with naphthyridinone inhibitor 5”. X-ray diffraction, 1 ligand (5SZ), 3 pockets (best druggability 0.64). MolNFT v1 #118320 on GenesisL1: 3D structure…

PDB
5EYC
Type
protein
Length
288 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatocyte growth factor receptor
EC
2.7.10.1
UniProt
P08581
Ligands
5SZ
Pockets
3 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatocyte growth factor receptor (EC 2.7.10.1)protein28843% helix, 16% strandP08581

Ligands and binding sites

  • 5SZ · 6-[(1~{R})-1-[8-fluoranyl-6-(3-methyl-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-1,6-naphthyridin-5-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12220.640.83255SZ
21010.380.7512empty
3960.350.7419empty

Compared structures

  • 5EYC · Crystal structure of c-Met in complex with naphthyridi inhibitor 5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.